Meaad Alsulami

Dr. Meaad Alsulami


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 December 2021 in Cureus
Verified
Journal Article
Open access
MGMohamed Garrada
Mohamed Garrada
MAMeaad Alsulami
Meaad Alsulami
SASamia Almutairi
Samia Almutairi
SAShahad M. Alessa
Shahad M. Alessa
AAAfaf F. Alselami
Afaf F. Alselami
KAKhaled I Al-Nouri
Khaled I Al-Nouri
This study aimed to establish and discuss the intraoperative and postoperative complications affecting patients who underwent cochlear implant (CI) surgery from the Cochlear Implant Program of King Abdulaziz University Hospital (KAUH), Jeddah, Saudi Arabia. A retrospective study was conducted by reviewing the medical records of 148 patients who underwent cochlear implantation at KAUH between 1999 and 2019. Postoperative complications were classified into minor and major complications. Minor complications resolved with minimal or no treatment. Major complications required additional surgery or hospitalization. Complications occurred in 28 (18.9%) patients. Minor complications occurred in 17 (11.5%) patients, which included otitis media (2%), facial palsy (1.4%), wound infection (1.4%), vertigo (1.4%), intraoperative cerebrospinal fluid (CSF) gusher (1.4%), tinnitus (1.4%), facial stimulation (1.4%), hematoma (0.7%), and chorda tympani nerve injury (0.7%). Major complications occurred in 11 (7.4%) patients. These included flap dehiscence/infection (2%), device failure (1.4%), device migration (1.4%), mastoiditis (1.4%), electrode damage during insertion (0.7%), and misplaced electrodes (0.7%). This study reported a low rate of surgical complications associated with CI, and most have been managed successfully without further complications. Our results prove that CI is a safe and reliable procedure, with a low complications rate when performed by experienced surgeons.

30 May 2022 in Cureus
Verified
Journal Article
Open access
ASAli A Samkari
Ali A Samkari
MAMeaad Alsulami
Meaad Alsulami
LBLinah Abdullah Bataweel
Linah Abdullah Bataweel
RARozan Altaifi
Rozan Altaifi
AAAhmed Altaifi
Ahmed Altaifi
NTNora H. Trabulsi
Nora H. Trabulsi
Breast cancer is the most frequent type of cancer as well as one of the main causes of cancer-related mortality in women. Human microbial dysbiosis, which has been related to a range of malignancies, is one of the variables that may impact the chance of developing breast disorders. In this review, we aimed to investigate the relationship between breast cancer and benign breast tumors with dysbiosis of the microbiome at different body sites. We performed a systematic review of MEDLINE, Scopus, Ovid, and Cochrane Library to identify original articles published until July 2020 that reported studies of breast disease and microbiota. Twenty-four original articles were included in the study, which looked at the features and changes in breast, gut, urine, lymph node, and sputum microbial diversity in patients with benign and malignant breast tumors. In breast cancer, the breast tissue microbiome demonstrated changes in terms of bacterial load and diversity; in benign breast tumors, the microbiome was more similar to a malignant tumor than to normal breast tissue. Triple-negative (TNBC) and triple-positive (TPBC) types of breast cancer have a distinct microbial pattern. Moreover, in breast cancer, gut microbiota displayed changes in the compositional abundance of some bacterial families and microbial metabolites synthesis. Our review concludes that breast carcinogenesis seems to be associated with microbial dysbiosis. This information can be further explored in larger-scale studies to guide new prophylactic, diagnostic, and therapeutic measures for breast cancer.

25 April 2022 in Cureus
Verified
Journal Article
Open access
MBMawaddah Batwa
Mawaddah Batwa
LALujain Alharthi
Lujain Alharthi
RGReem Ghazal
Reem Ghazal
MAMeaad Alsulami
Meaad Alsulami
RSRahaf Slaghour
Rahaf Slaghour
ABAbdullah Bakhsh
Abdullah Bakhsh
Background: Diabetic ketoacidosis (DKA) is a life-threatening complication of type 1 diabetes mellitus (T1DM) and a leading cause of morbidity and mortality in children. We aim to assess the frequency, clinical characteristics, biochemical findings, and outcomes of DKA at the onset of T1DM in young children and adolescents. Design and methods: This retrospective cohort study analyzed the medical records of patients ≤ 16 years old seen in the emergency department at King Abdulaziz University Hospital, Jeddah, Saudi Arabia, between April 2015 and June 2019. The severity of DKA was classified according to the International Society for Pediatric and Adolescent Diabetes (ISPAD) criteria. Results: Out of 207 patients with T1DM, 53 presented with DKA as a new onset. The mean age was 8.51 ± 3.81 years, with the majority being 5-10 years old (52.8%). Polyuria (98.1%), polydipsia (86.8%), weight loss (62.3%), and abdominal pain and vomiting (45.3%) were the most frequent symptoms. Mean random blood glucose was 424.09 ± 108.67 mg/dL and mean venous pH was 7.15 ± 0.36 mmol/L. Of patients, 66% had no associated complications, 24.4% had hypokalemia, 20.8% developed hypoglycemia, and 18.9% developed hyperchloremic metabolic acidosis. One patient had cerebral edema and coma. Based on metabolic acidosis, 24.5% had mild DKA, an equal percentage had severe DKA, and 9.4% had moderate DKA. Of patients, 88.7% were admitted to the pediatric ward and 15.1% to the intensive care unit. Conclusion: A total of 25% of patients diagnosed with T1DM below the age of 17 years presented with DKA. No permanent disabilities or deaths were reported. Forming a registry dedicated to T1DM is needed to follow up on these patients, especially among school-age children, as well as aid in the development of future research locally.